Dr. Heather Lynne Provencher, MD

Dr. Provencher practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Provencher's NPI, 1295024420, was assigned on March 28, 2011. Dr. Provencher graduated from The Robert Larner, M.D. College of Medicine in 2011. Dr. Provencher holds California license A125198.

Dr. Provencher's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Provencher's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Provencher is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Pacific Inpatient Medical Group. Dmand AI also links Dr. Provencher to 3 more hospitals and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Provencher practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Provencher's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Provencher is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Provencher's licenses on file in 2 states: California and Illinois.

Dmand AI lists acute respiratory failure, anemia, circulatory problems in extremities, congestive heart failure, electrolyte disorders, gastrointestinal infection, gastrointestinal inflammation and headaches among the conditions Dr. Provencher treats.

CMS data shows 844 Medicare services from Dr. Provencher across 7 procedure codes in 2024, for 286 Medicare patients. Medicare paid $90,508 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 286 Medicare patients who saw Dr. Provencher in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 57% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Provencher's median patient age at 70, with 45% women.

In 2024, Dr. Provencher wrote 173 Medicare Part D claims for 76 patients. 81% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $194 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Provencher for performance year 2024, reported as part of a group. Dr. Provencher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Provencher in 2007. 2007 was the busiest year, with 2. The most frequent topics are Gene Expression Regulation, Neoplastic, Homeodomain Proteins and Tamoxifen.

CMS Open Payments shows 3 general payments to Dr. Provencher from 3 drug and device companies in 2017. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $181.

Dmand AI lists 1 award for Dr. Provencher, most recently AOA Inductee 2011 in 2011.

Dr. Provencher graduated from The Robert Larner, M.D. College of Medicine in 2011. Dr. Provencher is a member of AOA.

Dr. Provencher is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.